COPD Hospitalization Registry

Overview

About this study

The purpose of this study is to assess and characterize health care utilization along with a survey-based parameter of demographic, functional and physiologic domains. In addition, we hope to see how additional hospitalizations or ER visits impact the trajectory of quality of life after a COPD related health care event. Patients that are eligible and willing to particpate will complete two questionniares at baseline and at 3, 6 and 12 months. The first questionnaire is about health care utilization. The second questionnaire is about breathing and quality of life.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Hospitalization within 3 months for COPD related causes (exacerbation (including COVID) and/or pneumonia)
Adults 40 years of age or older..

Exclusion Criteria:

Individuals not able to be reached by telephone.

Eligibility last updated 12/15/21. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Rochester, Minn. Mayo Clinic principal investigator Roberto Benzo, M.D.	Closed for enrollment

Mayo Clinic Location

Status

Rochester, Minn.

Mayo Clinic principal investigator

Roberto Benzo, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials